How Much Did K&K Pharmacy Raise?
Funding & Key Investors

K&K Pharmacy has successfully secured a significant capital injection, bringing its total funding to $90K. This latest financing round, which accounts for $90K, marks a pivotal moment in the organization's growth trajectory. By leveraging this substantial expansion capital, the firm is positioned to scale its specialized healthcare services across its core operational regions in Texas and New Mexico. The infusion of resources underscores investor confidence in the company's unique model of combining traditional prescription dispensing with advanced wellness and hormone consultation services.

What is K&K Pharmacy?

K&K Pharmacy
RetailDrug Stores & Pharmacies

Established in 2011, K&K Pharmacy has evolved into a cornerstone of community health within Bailey, Parmer, Lamb, Curry, and Castro counties. The company distinguishes itself through a multifaceted service offering that includes compounded medications, pharmaceutical-grade wellness supplements, and durable medical equipment. Beyond standard retail pharmacy operations, the organization emphasizes a clinical approach to patient care, featuring certified specialists in immunization and personalized hormone therapy. This integrated strategy allows K&K Pharmacy to bridge the gap between routine pharmaceutical needs and specialized, practitioner-led wellness solutions, effectively serving both individual patients and local healthcare providers in a highly fragmented regional market.

How much funding has K&K Pharmacy raised?

K&K Pharmacy has raised a total of $90K across 1 funding round:

2021

Debt

$90K

Debt (2021): $90K with participation from PPP

Key Investors in K&K Pharmacy

PPP

Public-Private Partnership

What's next for K&K Pharmacy?

With the recent influx of capital, K&K Pharmacy is expected to accelerate its strategic expansion, focusing on enhancing its compounding capabilities and broadening its reach in the regional healthcare landscape. The company is likely to prioritize the integration of advanced medical equipment distribution and the scaling of its immunization programs to meet rising demand for preventative care. As the firm transitions through this significant Series B/C stage, the focus will remain on operational excellence and the deepening of its clinical service portfolio. By maintaining its commitment to customized patient solutions, K&K Pharmacy is well-positioned to capture additional market share while reinforcing its status as a vital healthcare infrastructure provider in the rural and semi-urban corridors it serves.

See full K&K Pharmacy company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Apparel & Accessories RetailRetail
Jewelry & Watch RetailRetail
Record, Video & Book StoresRetail
Ecommerce PlatformsRetailManufacturingElectronics

Frequently Asked Questions Regarding K&K Pharmacy Financial Insights

What are the most recent funding rounds that K&K Pharmacy has completed, and what were the funding rounds?
K&K Pharmacy has recently completed 1 funding rounds: Debt on Feb 20, 2021.
What is the total amount of funding K&K Pharmacy has raised to date?
K&K Pharmacy has raised a total of $90K in funding to date.
How many funding rounds has K&K Pharmacy completed?
K&K Pharmacy has completed 1 funding rounds.
How much funding did K&K Pharmacy raise in its most recent funding round?
K&K Pharmacy raised $90K in its most recent funding round.
Who are the lead investors in K&K Pharmacy's latest funding round?
The lead investor in K&K Pharmacy's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in K&K Pharmacy's history?
The largest funding round in K&K Pharmacy's history was $90K.
See more information about K&K Pharmacy